Tatiana K Laktionova

Ms. Tatiana K Laktionova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
RGRichard C. Gerkin
Richard C. Gerkin
KOKathrin Ohla
Kathrin Ohla
MVMaria Geraldine Veldhuizen
Maria Geraldine Veldhuizen
Paule Valery JosephPaule Valery Joseph
Paule Valery Joseph
CKChristine E. Kelly
Christine E. Kelly
VPValentina Parma
Valentina Parma
Background: COVID-19 has heterogeneous manifestations, though one of the most common symptoms is a sudden loss of smell (anosmia or hyposmia). We investigated whether olfactory loss is a reliable predictor of COVID-19. Methods: This preregistered, cross-sectional study used a crowdsourced questionnaire in 23 languages to assess symptoms in individuals self-reporting recent respiratory illness. We quantified changes in chemosensory abilities during the course of the respiratory illness using 0-100 visual analog scales (VAS) for participants reporting a positive (C19+; n=4148) or negative (C19-; n=546) COVID-19 laboratory test outcome. Logistic regression models identified singular and cumulative predictors of COVID-19 status and post-COVID-19 olfactory recovery. Results: Both C19+ and C19-groups exhibited smell loss, but it was significantly larger in C19+ participants (mean±SD, C19+: -82.5±27.2 points; C19-: -59.8±37.7). Smell loss during illness was the best predictor of COVID-19 in both single and cumulative feature models (ROC AUC=0.72), with additional features providing negligible model improvement. VAS ratings of smell loss were more predictive than binary chemosensory yes/no-questions or other cardinal symptoms, such as fever or cough. Olfactory recovery within 40 days was reported for ∼50% of participants and was best predicted by time since illness onset. Conclusions: As smell loss is the best predictor of COVID-19, we developed the ODoR-19 tool, a 0-10 scale to screen for recent olfactory loss. Numeric ratings ≤2 indicate high odds of symptomatic COVID-19 (4<OR<10), which can be deployed when viral lab tests are impractical or unavailable.

26 October 2022 in Data in Brief
Verified
Journal Article
Open access
MKMaria Klyuchnikova
Maria Klyuchnikova
IKIlya Kvasha
Ilya Kvasha
TLTatiana K Laktionova
Tatiana K Laktionova
Vera V VoznessenskayaVera V Voznessenskaya
Vera V Voznessenskaya
This dataset describes olfactory perception of androstenone (5α-androst-16-en-3-one) in residents of central Russia (n=807, 9-84 years old). Based on previous studies, 3.13 × 10−3% androstenone was utilized for sensory testing. A modified two-alternative choice task with “no-difference” options was applied as an odor discrimination procedure. The participants rated the perceived odor intensity and pleasantness on 3-point categorical scales. The subsequent task was free odor identification. We used a survey to determine characteristics of our study population such as age, sex, ethnicity, olfactory abilities, smoking habits, respiratory tract diseases, perfume use, blood group. To examine sex differences in characteristics of participants, as well as in their perception of androstenone, we have applied one-way ANOVA for age variable and Chi-square tests for categorical variables. The dataset will be useful for assessing the impact of the aforementioned factors on the perception of volatile steroids. A wide range of researchers studying verbal descriptors of specific odors and cross-cultural differences in olfactory perception may reuse this dataset. Primarily, this dataset may benefit meat industry, as androstenone, which is perceived as an unpleasant odor by about a quarter of the population, significantly contributes to pork flavor.

30 April 2018 in Biology Bulletin
Verified
Journal Article
Closed access
PDF file
IKIlya Kvasha
Ilya Kvasha
TLTatiana K Laktionova
Tatiana K Laktionova
Vera V VoznessenskayaVera V Voznessenskaya
Vera V Voznessenskaya
The effects of the presentation rate of the domestic cat chemical L-felinine (0.05%) on the regulation of the estrous cycle in the house mouse were studied. It has been found that L-felinine has an...

5 September 2018 in Biology Bulletin
Verified
Journal Article
Closed access
PDF file
Vera V VoznessenskayaVera V Voznessenskaya
Vera V Voznessenskaya
MKMaria Klyuchnikova
Maria Klyuchnikova
ERE. I. Rodionova
E. I. Rodionova
TLTatiana K Laktionova
Tatiana K Laktionova
IKIlya Kvasha
Ilya Kvasha
AVAnna Voznesenskaya
Anna Voznesenskaya
We have tested the original version of the University of Pennsylvania Smell Identification Test (UPSIT) on a population of Central Russia including groups of different ages residing in the city area...

17 July 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
TLTatiana K Laktionova
Tatiana K Laktionova
IKIlya Kvasha
Ilya Kvasha
Vera V VoznessenskayaVera V Voznessenskaya
Vera V Voznessenskaya
Hormone changes across women’s menstrual cycles may lead to changes in their perceptions of chemical signals and their hormonal responses to these cues. The aim of the present study was to determine the role of menstrual cycle phase in the response to extracts of male axillary secretions (EMAS) in women. We tested healthy reproductive age and premenopausal women (n = 29). An EMAS/control solution was applied once every two hours during either the follicular or luteal phase, at which point saliva samples for luteinizing hormone (LH) and cortisol monitoring were collected. LH and cortisol concentrations were analyzed using the enzyme immunoassay (EIA) technique. Positive and Negative Affect Schedule (PANAS) and Visual Analogue Scales (VAS) scores were used to assess the participants’ moods. For the first time, we showed that EMAS may produce opposite effects on LH secretion depending on the menstrual cycle phase of the recipient. We observed a significant increase in the number of LH peaks (p = 0.0447) and their amplitudes (p = 0.0469) when EMAS was applied during the follicular phase, while the same application in the luteal phase lowered the amplitudes of LH peaks (p = 0.0382). For the first time, we showed that EMAS application increased salivary cortisol levels in reproductive age women relative to premenopausal women (p = 0.0032). PANAS scores revealed changes in positive and negative affect after EMAS application. Our data indicate the significance of the menstrual cycle phase for EMAS’ effects on LH secretion and mood, but not on cortisol secretion in women.

28 December 2025 in Biology
Verified
Journal Article
Open access
PDF file
TLTatiana K Laktionova
Tatiana K Laktionova
MKMaria Klyuchnikova
Maria Klyuchnikova
IKIlya Kvasha
Ilya Kvasha
OLOlga Laktionova
Olga Laktionova
Vera V VoznessenskayaVera V Voznessenskaya
Vera V Voznessenskaya
Sex differences in stress response continue to be understudied in basic physiological and behavioral research. The current study aimed to investigate the sex-specific effects of chronic stress in wild-derived house mice subjected to chronic unpredictable stress (CUS). The use of wild-derived mice enhanced the ecological validity of our stress model. We applied CUS for 5 weeks based on protocols previously established in laboratory mice, with regular weighting and welfare checks. Control mice were not subjected to stress. After the 5-week exposure, behavioral tests were performed, blood and hair samples were collected for corticosterone measurement, and stress-sensitive organ weights were assessed. Stressed females, but not stressed males, gained significantly less body weight over the entire CUS period. After CUS, mice tended to have higher adrenal and thymus weights. In stressed females, we observed significantly prolonged grooming time in the open field test and fewer immobility episodes in the tail suspension test (TST). Stressed males displayed significantly shorter immobility time in TST. Stressed males, but not stressed females, had significantly higher levels of hair corticosterone, with a similar tendency in plasma. Our results indicate different CUS coping strategies in males and females and raise a question about the development of different protocols for the assessment of stress responses in males and females.